Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.

Handels RL, Joore MA, Vos SJ, Aalten P, Ramakers IH, Rikkert MO, Scheltens P, Jansen WJ, Visser PJ, van Berckel BM, van Domburg P, Smid M, Hoff E, Hoogmoed J, Bouwman F, Claassen J, Leentjens AF, Wolfs CA, Severens JL, Verhey FR.

J Alzheimers Dis. 2016 Mar 31;52(3):875-85. doi: 10.3233/JAD-151120.

PMID:
27031483
2.

Compression to prevent PTS: a controversy?

Amin E, Joore MA, Ten Cate-Hoek AJ.

Phlebology. 2016 Mar;31(1 Suppl):41-7. doi: 10.1177/0268355516632986. Review.

PMID:
26916768
3.

Eliciting patients' preferences for elastic compression stocking therapy after deep vein thrombosis: potential for improving compliance.

Bouman AC, Ten Cate-Hoek AJ, Dirksen CD, Joore MA.

J Thromb Haemost. 2016 Mar;14(3):510-7. doi: 10.1111/jth.13228. Epub 2016 Feb 5.

PMID:
26670129
4.

How to integrate research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guidelines: A qualitative study among Dutch stakeholders.

Utens CM, Dirksen CD, van der Weijden T, Joore MA.

Health Policy. 2016 Jan;120(1):120-8. doi: 10.1016/j.healthpol.2015.10.005. Epub 2015 Oct 30.

PMID:
26563630
5.

Reviewing The Cost-Effectiveness of Chemotherapy and Targeted Therapy for Metastatic Breast Cancer.

Pouwels XG, Ramaekers BL, Joore MA.

Value Health. 2015 Nov;18(7):A703. doi: 10.1016/j.jval.2015.09.2632. Epub 2015 Oct 20. No abstract available.

PMID:
26533940
6.

Resource Use and Cost of Chemotherapeutic Treatment for Metastatic Breast Cancer in the Netherlands.

Pouwels XG, Ramaekers BL, Joore MA.

Value Health. 2015 Nov;18(7):A452. doi: 10.1016/j.jval.2015.09.1143. Epub 2015 Oct 20. No abstract available.

PMID:
26532544
7.

Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events: a Population-Based Cohort Study.

Tran-Duy A, Vanmolkot FH, Souverein PC, Hoes AW, de Boer A, Stehower CD, de Wit NJ, Joore MA, de Vries F.

Value Health. 2015 Nov;18(7):A378. doi: 10.1016/j.jval.2015.09.796. Epub 2015 Oct 20. No abstract available.

PMID:
26532134
8.

[A new perspective on measuring quality of life using the capability approach].

van Hoof M, Jeuring SF, Stokroos RJ, Joore MA.

Ned Tijdschr Geneeskd. 2015;159:A9234. Dutch.

PMID:
26469731
9.

The Authors' Reply: Comment on "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Grutters JP, van Asselt MB, Chalkidou K, Joore MA.

Pharmacoeconomics. 2015 Sep;33(9):983. doi: 10.1007/s40273-015-0321-8. No abstract available.

PMID:
26314283
10.

The Cost-Effectiveness of Different Hearing Screening Strategies for 50- to 70-Year-Old Adults: A Markov Model.

Linssen AM, Anteunis LJ, Joore MA.

Value Health. 2015 Jul;18(5):560-9. doi: 10.1016/j.jval.2015.03.1789. Epub 2015 May 14.

PMID:
26297083
11.

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.

Seferina SC, Lobbezoo DJ, de Boer M, Dercksen MW, van den Berkmortel F, van Kampen RJ, van de Wouw AJ, de Vries B, Joore MA, Peer PG, Voogd AC, Tjan-Heijnen VC.

Oncologist. 2015 Aug;20(8):856-63. doi: 10.1634/theoncologist.2015-0006. Epub 2015 Jun 22.

PMID:
26099745
12.

Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach.

Bouman AC, ten Cate-Hoek AJ, Ramaekers BL, Joore MA.

PLoS One. 2015 Jun 15;10(6):e0130531. doi: 10.1371/journal.pone.0130531. eCollection 2015.

13.

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.

Handels RL, Joore MA, Tran-Duy A, Wimo A, Wolfs CA, Verhey FR, Severens JL.

Alzheimers Dement. 2015 Aug;11(8):896-905. doi: 10.1016/j.jalz.2015.02.009. Epub 2015 Jun 9.

PMID:
26071009
14.

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.

Tran-Duy A, Vanmolkot FH, Joore MA, Hoes AW, Stehouwer CD.

Int J Clin Pract. 2015 Oct;69(10):1088-111. doi: 10.1111/ijcp.12634. Epub 2015 Apr 6.

PMID:
25846476
15.

The cost-effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care.

Hendriksen JM, Geersing GJ, van Voorthuizen SC, Oudega R, Ten Cate-Hoek AJ, Joore MA, Moons KG, Koffijberg H.

Expert Rev Mol Diagn. 2015 Jan;15(1):125-36. doi: 10.1586/14737159.2015.976202.

PMID:
25537569
16.
17.

Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines: A Proposal for A Taxonomy of Preference-Related Terms.

Utens CM, Joore MA, van dW, Dirksen CD.

Value Health. 2014 Nov;17(7):A583-4. doi: 10.1016/j.jval.2014.08.1982. Epub 2014 Oct 26. No abstract available.

18.

Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain: A Nice Diagnostic Assessment.

Ramaekers BL, Armstrong N, Joore MA, Westwood M, Whiting P, Thokala P, Ross J, Kleijnen J, Severens J, van AA.

Value Health. 2014 Nov;17(7):A490. doi: 10.1016/j.jval.2014.08.1444. Epub 2014 Oct 26. No abstract available.

19.

Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.

Vaidya A, Joore MA, ten Cate-Hoek AJ, ten Cate H, Severens JL.

Biomark Med. 2014;8(8):989-99. doi: 10.2217/bmm.14.45.

PMID:
25343671
20.

Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes.

Handels RL, Wolfs CA, Aalten P, Bossuyt PM, Joore MA, Leentjens AF, Severens JL, Verhey FR.

BMC Neurol. 2014 Oct 4;14:190. doi: 10.1186/s12883-014-0190-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk